| Defining the intensity of conditioning regimens: working definitions A Bacigalupo, K Ballen, D Rizzo, S Giralt, H Lazarus, V Ho, J Apperley, ... Biology of blood and marrow transplantation 15 (12), 1628-1633, 2009 | 1843 | 2009 |
| Targeting natural killer cells and natural killer T cells in cancer E Vivier, S Ugolini, D Blaise, C Chabannon, L Brossay Nature Reviews Immunology 12 (4), 239-252, 2012 | 1033 | 2012 |
| Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older … M Aoudjhane, M Labopin, NC Gorin, A Shimoni, T Ruutu, HJ Kolb, ... Leukemia 19 (12), 2304-2312, 2005 | 522 | 2005 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 498 | 2017 |
| Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine … Stem Cell Trialists’ Collaborative Group Journal of clinical oncology: official journal of the American Society of …, 2005 | 455 | 2005 |
| Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de … D Blaise, M Kuentz, C Fortanier, JH Bourhis, N Milpied, L Sutton, JP Jouet, ... Journal of Clinical Oncology 18 (3), 537-537, 2000 | 454 | 2000 |
| Outcome of treatment in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia—results of the prospective multicenter LALA-94 trial H Dombret, J Gabert, JM Boiron, F Rigal-Huguet, D Blaise, X Thomas, ... Blood, The Journal of the American Society of Hematology 100 (7), 2357-2366, 2002 | 453 | 2002 |
| Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 51 (7), 906-912, 2016 | 438 | 2016 |
| Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ... Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015 | 427 | 2015 |
| Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias D Maraninchi, D Blaise, B Rio, V Leblond, F Dreyfus, E Gluckman, ... The lancet 330 (8552), 175-178, 1987 | 414 | 1987 |
| An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure … AJ Peniket, MC Ruiz de Elvira, G Taghipour, C Cordonnier, E Gluckman, ... Bone marrow transplantation 31 (8), 667-678, 2003 | 402 | 2003 |
| Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 50 (6), 781-789, 2015 | 397 | 2015 |
| Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire S Le Gouill, N Milpied, A Buzyn, R Peffault De Latour, JP Vernant, ... Journal of Clinical Oncology 26 (14), 2264-2271, 2008 | 362 | 2008 |
| Hematopoietic stem cell transplantation for patients with AML in first complete remission JJ Cornelissen, D Blaise Blood, The Journal of the American Society of Hematology 127 (1), 62-70, 2016 | 358 | 2016 |
| Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 … G Socié, RA Clift, D Blaise, A Devergie, O Ringden, PJ Martin, ... Blood, The Journal of the American Society of Hematology 98 (13), 3569-3574, 2001 | 333 | 2001 |
| Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as … D Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergie, JP Jouet, ... | 331 | 1992 |
| Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation C Toffalori, L Zito, V Gambacorta, M Riba, G Oliveira, G Bucci, M Barcella, ... Nature medicine 25 (4), 603-611, 2019 | 323 | 2019 |
| Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry D Farge, J Passweg, JM Van Laar, Z Marjanovic, C Besenthal, J Finke, ... Annals of the rheumatic diseases 63 (8), 974-981, 2004 | 314 | 2004 |
| Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia N Dhédin, A Huynh, S Maury, R Tabrizi, K Beldjord, V Asnafi, X Thomas, ... Blood, The Journal of the American Society of Hematology 125 (16), 2486-2496, 2015 | 300 | 2015 |
| Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer … JY Cahn, JP Klein, SJ Lee, N Milpied, D Blaise, JH Antin, V Leblond, ... Blood 106 (4), 1495-1500, 2005 | 299 | 2005 |
